Physician

Aaron Tea, NP

According to 2025 Medicare claims, Aaron Tea, NP (NPI: 1285097998) practices nurse practitioner in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (NPI: 1770515280; TIN: 951750445) and primary practice location at 91706-5806. Tea is affiliated with the Astrana Care Partners ACO (ACO ID: A5450), participating under the MSSP model.

Tea's data goes back to 2015 and runs through 2024. Part D data shows 3,165 prescription claims across 405 beneficiaries totaling $365,218 in drug costs, led by Jardiance (Empagliflozin). DME data shows 22 claims. Open Payments data shows 29 records totaling $672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $23,062 to $365,218. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $240 to $14,713.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$245K$489K2016 Drug cost: $23,062 (USD; Tot_Drug_Cst)2017 Drug cost: $91,195 (USD; Tot_Drug_Cst)2018 Drug cost: $226,541 (USD; Tot_Drug_Cst)2019 Drug cost: $218,597 (USD; Tot_Drug_Cst)2020 Drug cost: $253,180 (USD; Tot_Drug_Cst)2021 Drug cost: $295,468 (USD; Tot_Drug_Cst)2022 Drug cost: $454,108 (USD; Tot_Drug_Cst)2023 Drug cost: $489,451 (USD; Tot_Drug_Cst)2024 Drug cost: $365,218 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201682341$23,062
20171181,053$91,195
20181341,538$226,541
20191281,447$218,597
20201211,463$253,180
20212252,079$295,468
20222623,088$454,108
20232943,333$489,451
20244053,165$365,218

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$662$1.3K2017 Medicare payment: $1,324 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $189 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $143 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $258 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R24$1,324
2018N/R12$189
2019N/R11$143
2020N/RN/RN/R
2021N/R22$258
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin1135,550$101,405
JanuviaSitagliptin Phosphate422,160$36,680
Trelegy ElliptaFluticasone/Umeclidin/Vilanter461,500$29,643
EntrestoSacubitril/Valsartan191,034$20,860
RybelsusSemaglutide18690$19,386

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$672Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aaron Tea, NP?

Tedicare shows public-source Medicare data for Aaron Tea, NP (NPI 1285097998), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Tea, NP have ACO affiliation data?

Aaron Tea, NP is shown with ACO affiliation data for Astrana Care Partners ACO (MSSP, ACO ID A5450).

What billing organization is linked to Aaron Tea, NP?

Aaron Tea, NP is linked to SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (billing NPI 1770515280) in the available physician profile data.

Does Aaron Tea, NP have Open Payments data?

Aaron Tea, NP has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.